StrokeENDPredictor-19: Setting New Prediction Model in Neurological Prognosis in Acute Ischemic Stroke.

IF 5.4 2区 医学 Q3 ENGINEERING, BIOMEDICAL
Lingli Li, Hongxiao Li, Miaowen Jiang, Jing Fang, Ning Ma, Jianzhuo Yan, Chen Zhou
{"title":"StrokeENDPredictor-19: Setting New Prediction Model in Neurological Prognosis in Acute Ischemic Stroke.","authors":"Lingli Li, Hongxiao Li, Miaowen Jiang, Jing Fang, Ning Ma, Jianzhuo Yan, Chen Zhou","doi":"10.1007/s10439-025-03838-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Early Neurological Deterioration (END) following intravenous thrombolysis (IVT) highlights potential risks in current management strategies for acute ischemic stroke. Early identification of at-risk patients could enhance treatment efficacy. This study aims to develop an advanced AI predictive model that improves accuracy in forecasting END while ensuring interpretability for clinical application.</p><p><strong>Methods: </strong>This prospective cohort study included 970 patients with acute ischemic stroke who underwent IVT. Data from 365 patients were used for model development and internal validation, while data from 605 patients were utilized for external validation. Five machine learning models were developed and compared using evaluation metrics such as accuracy and AUC. Feature selection and model optimization were performed using the XGBoost algorithm and SHapley Additive exPlanations (SHAP) method, resulting in the StrokeENDPredictor-19 model.</p><p><strong>Results: </strong>Among the five models, XGBoost demonstrated superior performance with an internal validation accuracy of 91% (AUC = 0.96) and external validation accuracy of 90% (AUC = 0.95). Notably, this study established cutoff values for critical clinical features, providing quantifiable reference standards for practical applications.</p><p><strong>Conclusion: </strong>The StrokeENDPredictor-19 model offers neurologists a valuable tool for forecasting the likelihood of END in patients receiving IVT therapy, thereby supporting more precise clinical decision-making.</p>","PeriodicalId":7986,"journal":{"name":"Annals of Biomedical Engineering","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10439-025-03838-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Early Neurological Deterioration (END) following intravenous thrombolysis (IVT) highlights potential risks in current management strategies for acute ischemic stroke. Early identification of at-risk patients could enhance treatment efficacy. This study aims to develop an advanced AI predictive model that improves accuracy in forecasting END while ensuring interpretability for clinical application.

Methods: This prospective cohort study included 970 patients with acute ischemic stroke who underwent IVT. Data from 365 patients were used for model development and internal validation, while data from 605 patients were utilized for external validation. Five machine learning models were developed and compared using evaluation metrics such as accuracy and AUC. Feature selection and model optimization were performed using the XGBoost algorithm and SHapley Additive exPlanations (SHAP) method, resulting in the StrokeENDPredictor-19 model.

Results: Among the five models, XGBoost demonstrated superior performance with an internal validation accuracy of 91% (AUC = 0.96) and external validation accuracy of 90% (AUC = 0.95). Notably, this study established cutoff values for critical clinical features, providing quantifiable reference standards for practical applications.

Conclusion: The StrokeENDPredictor-19 model offers neurologists a valuable tool for forecasting the likelihood of END in patients receiving IVT therapy, thereby supporting more precise clinical decision-making.

StrokeENDPredictor-19:建立急性缺血性脑卒中神经预后预测新模型。
背景和目的:静脉溶栓(IVT)后的早期神经功能恶化(END)突出了当前急性缺血性卒中管理策略的潜在风险。早期发现高危患者可提高治疗效果。本研究旨在开发一种先进的人工智能预测模型,以提高预测END的准确性,同时确保临床应用的可解释性。方法:本前瞻性队列研究纳入970例急性缺血性脑卒中患者行静脉内静脉注射。来自365名患者的数据用于模型开发和内部验证,而来自605名患者的数据用于外部验证。开发了五种机器学习模型,并使用准确性和AUC等评估指标进行了比较。使用XGBoost算法和SHapley Additive explanation (SHAP)方法进行特征选择和模型优化,得到StrokeENDPredictor-19模型。结果:5个模型中,XGBoost的内部验证准确率为91% (AUC = 0.96),外部验证准确率为90% (AUC = 0.95)。值得注意的是,本研究建立了关键临床特征的临界值,为实际应用提供了可量化的参考标准。结论:StrokeENDPredictor-19模型为神经学家预测接受IVT治疗的患者发生END的可能性提供了一个有价值的工具,从而支持更精确的临床决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of Biomedical Engineering
Annals of Biomedical Engineering 工程技术-工程:生物医学
CiteScore
7.50
自引率
15.80%
发文量
212
审稿时长
3 months
期刊介绍: Annals of Biomedical Engineering is an official journal of the Biomedical Engineering Society, publishing original articles in the major fields of bioengineering and biomedical engineering. The Annals is an interdisciplinary and international journal with the aim to highlight integrated approaches to the solutions of biological and biomedical problems.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信